Sarepta Therapeutics Zooms Higher on Early Data Rally Promising
Sarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Explore Visa cards that offer the best cashback without any annual fees. Start saving on your purchases effortlessly.
28,655 articlesSarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Toncoin and MemeCore surged roughly 30% as Bitcoin touched $81,000, signaling renewed trader interest amid a choppy m...
New neuroscience findings link AI-assisted homework to a sharp decline in student cognitive engagement, prompting pol...
A surprise shift in BOJ policy sent traders scrambling, triggering large outflows from U.S. spot Bitcoin ETFs and eye...
Two more Ethereum Foundation researchers have resigned, deepening a wave of departures that could reshape the nonprof...
The Verus bridge exploit ends with a partial recovery: 4,052 ETH returned within 24 hours, leaving a $2.8 million whi...
Memory-chip giants Micron and SK Hynix push into the $1 trillion market-cap club, signaling renewed confidence in AI-...
In early 2026, investigators flagged AI-assisted conversations linked to violent acts, prompting urgent questions abo...
As roughly $1.8 billion in crypto options approach expiration on Deribit, traders weigh whether will markets continue...
As market nerves remain tied to crude prices, the VanEck Energy Income ETF (EINC) continues to offer a solid 3.2%-3.6...
A retail investor endured an 80% drawdown in a 3X semiconductor ETF, then capitalized on an AI-fueled rebound to turn...
A leading technology analyst questions Intel's current stock value, arguing the market is pricing an AI cycle far int...